The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study.
 
Sara Elena Rebuzzi
No Relationships to Disclose
 
Francesco Atzori
No Relationships to Disclose
 
Marilena Di Napoli
Consulting or Advisory Role - AstraZeneca/Merck; ipsen
Speakers' Bureau - AstraZeneca/Merck; Bristol-Myers Squibb
 
Marco Stellato
No Relationships to Disclose
 
Marco Messina
Consulting or Advisory Role - Sanofi
 
Silvia Chiellino
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Roche
 
Francesca Vignani
No Relationships to Disclose
 
Alessia Cavo
No Relationships to Disclose
 
Hector J. Soto Parra
No Relationships to Disclose
 
Giandomenico Roviello
No Relationships to Disclose
 
Veronica Prati
No Relationships to Disclose
 
Davide Bimbatti
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche
 
Melissa Bersanelli
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer; Roche; Sanofi (Inst); Seqirus
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer/EMD Serono; Pierre Fabre
 
Federico Paolieri
No Relationships to Disclose
 
Paolo Andrea Zucali
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
 
Emanuela Fantinel
No Relationships to Disclose
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Alessio Signori
No Relationships to Disclose
 
Giuseppe Fornarini
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi